Bioptik Technology

Bioptik Technology CROIC

The Cash Return on Invested Capital (CROIC) of Bioptik Technology (4161.TWO) as of Nov 4, 2026 is 3.44 %. In the previous year, Cash Return on Invested Capital (CROIC) was 13.87 % — a change of -75.19% (lower).

CROIC

3.44 %

YoY

-75.19%

Last updated:

Cash Return on Invested Capital (CROIC) of Bioptik Technology is 2025 3.44 % . Cash Return on Invested Capital (CROIC) of Bioptik Technology was 2024 13.87 % . It decreases by -75.19% lower compared to the previous year.

The Bioptik Technology CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
-0.82 TWD
Jan 1, 2019
1.28 TWD
Jan 1, 2020
-0.48 TWD
Jan 1, 2021
-4.43 TWD
Jan 1, 2022
2.76 TWD
Jan 1, 2023
13.03 TWD
Jan 1, 2024
13.87 TWD
Jan 1, 2025
3.44 TWD
The Bioptik Technology CROIC history
YEARCROICYoY
3.44 %-75.19%
13.87 %+6.47%
13.03 %+372.72%
2.76 %-162.20%
-4.43 %+819.59%
-0.48 %-137.50%
1.28 %-256.84%
-0.82 %-80.94%
-4.30 %-9.16%
-4.73 %-41.64%
-8.11 %-34.41%
-12.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bioptik Technology Stock analysis

What does Bioptik Technology do? Bioptik Technology, Inc. generates revenue through the sale of hyaluronic acid-based skincare products and medical diagnostic equipment. The company sells multifunctional blood sugar, cholesterol, uric acid, and heme detectors under the Easy Mate and Easy Touch brands, along with testing paper products for these parameters. Its cosmetic line, distributed under ACUREAL, includes toning lotions, essences, facial masks, and face cleaning products. Domestic and international markets are the primary sales channels for both product categories. The firm targets healthcare providers and consumers seeking at-home medical monitoring solutions through its Easy Mate and Easy Touch devices. ACUREAL skincare products appeal to customers interested in biological and medical cosmetics for daily skincare routines. Bioptik Technology focuses on the domestic market and overseas markets for product distribution, ensuring broad accessibility across different regions. Easy Mate and Easy Touch are the key medical equipment brands, while ACUREAL represents the cosmetic segment. The company's product portfolio combines medical diagnostics with skincare, serving two distinct consumer segments: health-conscious individuals monitoring vital metrics and users seeking specialized skincare solutions. This dual approach allows Bioptik Technology to leverage its research and development capabilities across both medical and cosmetic applications. Bioptik Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioptik Technology stock

Cash Return on Invested Capital (CROIC) of Bioptik Technology is 3.44 % in 2025.

Cash Return on Invested Capital (CROIC) of Bioptik Technology changed from 13.87 % to 3.44 %, representing a -75.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Bioptik Technology since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Bioptik Technology with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Bioptik Technology

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Bioptik Technology